Skip to main content

Table 3 Results of linear regression analysis investigating the effect of age, gender and malaria status as determined by microscopyb on logged antibody levels to AMA1, MSP1, MSP2, NANP and IgE

From: Genetic determinants of anti-malarial acquired immunity in a large multi-centre study

Factor

Anti-AMA1 levels (n = 10,137)

Anti-MSP1 levels (n = 10,200)

Anti-MSP2 levels (n = 10,283)

Anti-NANP levels (n = 5,531)a

Total IgE levels (n = 4,961)a

Beta (95 % CI)

p-value

Beta (95 % CI)

p-value

Beta (95 % CI)

p-value

Beta (95 % CI)

p-value

Beta (95 % CI)

p-value

Age (years)

 <1

0

 

0

 

0

 

0

 

0

 

 1–2

0.04 (−0.09 to 0.17)

0.576

−0.10 (−0.22 to 0.01)

0.083

0.16 (0.05 to 0.28)

0.006

0.30 (0.04 to 0.55)

0.023

0.09 (−0.17 to 0.35)

0.508

 2–5

0.25 (0.15 to 0.35)

<0.001

0.08 (−0.01 to 0.17)

0.087

0.29 (0.20 to 0.38)

<0.001

0.50 (0.30 to 0.71)

<0.001

0.09 (−0.12 to 0.30)

0.398

 5–15

0.57 (0.47 to 0.67)

<0.001

0.37 (0.28 to 0.45)

<0.001

0.61 (0.52 to 0.69)

<0.001

0.87 (0.67 to 1.07)

<0.001

0.19 (−0.01 to 0.40)

0.066

 15–30

0.55 (0.46 to 0.65)

<0.001

0.65 (0.57 to 0.74)

<0.001

0.72 (0.63 to 0.81)

<0.001

1.43 (1.23 to 1.63)

<0.001

0.22 (0.02 to 0.43)

0.034

 >30

0.53 (0.43 to 0.63)

<0.001

0.81 (0.72 to 0.90)

<0.001

0.72 (0.63 to 0.81)

<0.001

1.61 (1.40 to 1.81)

<0.001

0.14 (−0.07 to 0.35)

0.179

Gender

 Female

0

 

0

 

0

 

0

 

0

 

 Male

−0.03 (−0.07 to 0)

0.058

−0.08 (−0.11 to −0.05)

<0.001

−0.05 (−0.07 to −0.02)

0.002

−0.07 (−0.11 to −0.03)

0.004

0.12 (0.09 to 0.16)

<0.001

Microscopy result

 

 Negative

0

 

0

 

0

 

0

 

0

 

 Positive

0.17 (0.13 to 0.22)

<0.001

0.15 (0.11 to 0.19)

<0.001

0.21 (0.18 to 0.25)

<0.001

−0.03 (−0.08 to −0.02)

0.263

0.06 (0.01 to 0.11)

0.021

  1. Results shown as betas, which indicate the direction of effect of the clinical covariate on antibody levels. Beta < 0 indicate a decrease in antibody levels and beta > 0 indicate an increase in antibody levels. 95 % confidence intervals that do not span 0 indicate an effect that is significant at p = 0.05.
  2. NB: CI confidence interval; results significant at 0.05 level are highlighted in italics.
  3. aData not available for Tanzania (Moshi).
  4. b Also adjusted for village (>20), ethnicity (>20), sample month (>20) and study; results not shown but ANOVA p-values were <0.001 for all antibodies.